CIERRA JENNINGS: Open Payments
NPI 1538694971 · LEESBURG, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 48 payments from 13 companies in 2025. Trend: 2023 $324 · 2024 $1,333 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $239 |
| ABBVIE INC. | 18 | $209 |
| PFIZER INC. | 5 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Atland Pharmaceuticals, LLC | 1 | $46 |
| Lundbeck LLC | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Amgen Inc. | 2 | $30 |
| Dexcom, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: AIRSUPRA, VRAYLAR, NURTEC ODT, LEQVIO, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, REXULTI, Kerendia, QULIPTA.
Industry payments across AL — which companies pay providers there.
